Detection Technology Oy · OMXHEX:DETEC
Detection Technology Oy — Q3 2020 Earnings Presentation
13 slides from Detection Technology Oy's earnings presentation, Oct 27, 2020
Slide 1: Q3 2020 January–September Business review
Q3 2020 January–September Business review President and CEO Hannu Martola | 27 October 2020
Slide 2: Q3 net sales and EBIT overview
Q3 › 20.6 -23.4 2.8 13.4 net sales, €m net sales change-% EBIT excluding NRI, €m EBIT-% excluding NRI (26.9) (9.5) (5.1) (19.1) 2 27.10.2020 Detection Technology | Business review January–September 2020
Slide 3: Q3 2020 summary
Q3 2020 › Presented little surprises and was a sequel to Q2 both in terms of market dynamics and actuals COVID-19 continued to batter the security market, and the medical CT market had a fair tailwind Weak demand in security applications resulted in a decrease in y-o-y net sales Profitability remain
Slide 4: Net sales by quarter
NET SALES BY QUARTER (EUR 1,000) 30 000 25 000 20 000 15 000 10 000 5 000 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 2017 2018 2019 2020 4 27.10.2020 Detection Technology | Business review January–September 2020
Slide 5: Operating profit
OPERATING PROFIT (EUR 1,000) 8 000 30% 7 000 25.4% 25% 6 000 22.9% 21.4% 21.0% 20.3% 19.1% 20% 19.6% 19.4% 19.2% 5 000 17.5% 16.7% 15.6% 4 000 15% 13.4% 12.3% 3 000 10% 2 000 5.9% 5% 1 000 0 0% Q117 Q217 Q317 Q417 Q118 Q218 Q318 Q418 Q119 Q219 Q319 Q419 Q120 Q220 Q320 EBIT excluding NRI (EUR 1,000)
Slide 6: Sales split Q3 2020 by business unit and region
SALES SPLIT Q3 2020 BY BUSINESS UNIT › BY REGION › 26% NET SALES NET SALES 49% 20.6 51% 20.6 €m 8% €m 66% MBU SBU APAC -28.8 NET SALES €m10.1 10.6 NET SALES €m AMERICAS -26.3 YOY CHANGE-% 20.2 -43.1 YOY CHANGE-% EMEA -4.0 YOY CHANGE-% 6 27.10.2020 Detection Technology | Business review January–Septe
Slide 7: Q1-Q3 net sales and EBIT overview
Q1-Q3 › 61.7 -20.4 6.5 10.6 net sales, €m net sales change-% EBIT excluding NRI, €m EBIT-% excluding NRI (77.5) (13.5) (13.8) (17.8) 7 27.10.2020 Detection Technology | Business review January–September 2020
Slide 8: Sales split Q1-Q3 2020 by business unit and region
SALES SPLIT Q1-Q3 2020 BY BUSINESS UNIT › BY REGION › 23% NET SALES NET SALES 46% 61.7 54% 61.7 11% €m €m 66% MBU SBU APAC -19.2 NET SALES €m28.3 33.3 NET SALES €m AMERICAS -32.8 YOY CHANGE-% 13.2 -36.4 YOY CHANGE-% EMEA -16.3 YOY CHANGE-% 8 27.10.2020 Detection Technology | Business review January–
Slide 9: Key figures
KEY FIGURES Q3 2020 Q3 2019 Q1-Q3 2020 Q1-Q3 2019 FY 2019 Net sales, EUR 1,000 20,628 26,934 61,653 77,459 102,480 Change in net sales, % -23.4% 9.5% -20.4% 13.5% 9.1% Operating profit excluding non-recurring items (NRI) 2,758 5,148 6,528 13,807 17,719 Operating margin excluding NRI, % 13.4% 19,1% 1
Slide 10: Strategy
STRATEGY › Has continued developing its business in line with the DT-2025 strategy Launched a 1412 panel size in its X-Panel product family, expanded the product family from dental applications to industrial imaging, which is a strategically significant milestone Moved French operations to new facil
Slide 11: Business outlook
BUSINESS OUTLOOK 5% 6% 5% MEDICAL MARKET SECURITY MARKET INDUSTRIAL MARKET annual growth rate annual growth rate annual growth rate • Estimates the market disruption to continue in all of its main markets, with the exception of medical CT imaging, and 2020 and H1 2021 annual growth rates in all othe
Slide 12: Financial targets
FINANCIAL TARGETS › MEDIUM TERM Annual MEDIUM TERM Operating ANNUAL Dividend or sales growth margin returned capital >10% ≥15% 30-60% 12 27.10.2020 Detection Technology | Business review January–September 2020
Slide 13: Detection Technology
Detection Technolo: FOREKNOW. FORESAVE?® 2